Dr. Chen Qiang, Senior Technical Director of 360AI Research Institute: Current Status and Breakthrough Points of China's New Generation of Artificial Intelligence Key Common Technology System
Targets, indications, and drug trials are compared with 2017 approved domestic and international anti-tumor drugs